
Extensive study identifies over a dozen existing drugs as potential COVID-19 therapies FDA-approved drugs or experimental drugs with ample health data could be rapidly tested in humans for treatment of COVID-19.
June 03, 2021
LA JOLLA, CA Mining the world's most comprehensive drug repurposing collection for COVID-19 therapies, scientists have identified 90 existing drugs or drug candidates with antiviral activity against the coronavirus that's driving the ongoing global pandemic.
Among those compounds, the Scripps Research study identified four clinically approved drugs and nine compounds in other stages of development with strong potential to be repurposed as oral drugs for COVID-19, according to results published June 3 in the journal Nature Communications.
Of the drugs that prevented the coronavirus from replicating in human cells, 19 were found to work in concert with or boost the activity of remdesivir, an antiviral therapy approved for treatment of COVID-19.
While we now have effective vaccines against COVID-19, we still lack highly effective antiviral drugs that can prevent COVID-19 infections or stop them from worsening, says Peter Schultz, PhD, President and CEO of Scripps Research.
Our results raise the possibility of a number of promising avenues for repurposing existing oral medications with efficacy against SARS-CoV-2, he adds. We have identified promising existing drugs and are also leveraging our findings to develop optimized antivirals that will be more effective against SARS-CoV-2, including variants and drug resistant strains, as well as against other coronaviruses that currently exist or might emerge in future.
In a collaboration between Calibr, the drug discovery division of Scripps Research, and a team of researchers in the institute's Department of Immunology and Microbiology, the study tested more than 12,000 drugs in two different types of human cells infected with SARS-CoV-2.
The drugs used in the study came from the ReFRAME drug repurposing library, which was established by Calibr in 2018 with support from the Bill & Melinda Gates Foundation to tackle areas of urgent unmet medical need, especially neglected tropical diseases. The collection contains FDA-approved drugs and other experimental compounds that have been tested for safety in humans.
Early in the COVID-19 pandemic, we saw that ReFRAME could be leveraged to screen for hits against SARS-CoV-2, says Arnab Chatterjee, PhD, vice president of medicinal chemistry at Calibr. In the months that followed, we launched many scientific collaborations to speed drug discovery, both internally at Scripps Research and with partners nationally and internationally.
In the Scripps Research study, the scientists treated two different types of laboratory-cultured SARS-CoV-2-infected human cells with each of the 12,000 drugs from ReFRAME. After 24 or 48 hours, they measured the level of viral infection in the cells to determine if the drugs prevented the virus from replicating. In some cases, they applied two drugs at a time to see if the compounds would work together against the virus.
Some of the most effective antiviral strategies are cocktails' in which patients are given several different drugs to combat the infection, such as those used to treat HIV infections, says the study's corresponding author Thomas Rogers, MD, PhD, an adjunct assistant professor in the Department of Immunology and Microbiology at Scripps Research and assistant professor of Medicine at UC San Diego.
From the thousands of drugs screened, the researchers identified a total of 90 compounds that prevented SARS-CoV-2 from replicating in at least one of the human cell lines. Of those, 13 had the highest potential to be repurposed as COVID-19 therapies, based on their potency, cell line-independent activity or a likely mechanism of action, pharmacokinetic properties and human safety profiles.
Four of the drugs halofantrine, nelfinavir, simeprevir and manidipine are already FDA approved and nine others are in various stages of the drug development process.
From the drug combination screens, the researchers found 19 drugs that had an additive effect when administered with remdesivir, the antiviral produced by the pharmaceutical company Gilead that is FDA approved for use in patients diagnosed with COVID-19. An additive effect means that the drugs were both active against the virus when applied together.
The potential advantage of a therapeutic strategy that uses a combination of drugs is that taking a lower dose of any one drug could reduce the risk of side effects of that drug, says Malina Bakowski, PhD, the lead author on the Nature Communications paper and principal investigator at Calibr.
Two additional drugs went a step further to have a synergistic effect on remdesivir, meaning the drugs heightened remdesivir's ability to suppress the virus. These two drugs were riboprine, a compound that's been tested as a preventative for nausea and surgical infection, and 10-deazaaminopterin, a derivative of the vitamin folic acid.
Based on the results of cell culture screens, the researchers tested the best-performing drug candidates in human tissue cells and an animal model to determine which are most likely to work in human patients. Building on their success in identifying potential COVID-19 therapies, the Scripps Research team is continuing to advance other promising candidates through their drug discovery pipeline.
The results from the cellular assays and animal models are very promising and the need for medical remedies to address COVID-19 remains urgent, says Schultz. It is critical we proceed with the utmost rigor to determine what is safe and effective, as diligence is the most expedient path to finding new therapies that will make a difference for patients.
Results from the screen of the
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
20/11/2026
Beam Dynamics has introduced new Model Context Protocol (MCP) support, expanding how customers can work with the live operational data held in Beam. The new cap...
20/11/2026
Re:Vision Effects Cyber Week Sale Nov 24 to Nov 30
Pierre Jasmin November 19, 2026
0 Comments
Long time friends of the COW are up with a big sale!
Us...
20/11/2026
Avid is offering up to 33% off annual subscriptions!
Brie Clayton November 19, 2026
0 Comments
Hero image courtesy Deposit Photos
Pro Tools
Pro To...
19/11/2026
With a sports-bar vibe and all the teams onsite in a huge atrium in Ballpark Vil...
19/11/2026
The senior from Phoenix and England is balancing life as a Division I tennis player with a growing career behind the microphone
The future of live sports produ...
19/11/2026
RED Digital Cinema and Colorfront have partnered to integrate native Colorfront color management into RED Connect, letting productions apply Colorfront's co...
19/11/2026
SMPTE has published an engineering report summarizing an industry survey by its Study Group on Content Provenance and Authenticity in Media. The findings point ...
19/11/2026
CTech and Skyline Communications have announced a partnership to deliver integra...
19/11/2026
Euskal Irrati Telebista (EITB), the Basque Country's public media group, has completed Phase 1 of a five-studio renewal with the commissioning of a Lawo IP ...
19/11/2026
The Esports Foundation (EF) has announced an expanded Road to ENC 2027 for the E...
19/11/2026
All Women's Sports Network (AWSN) held its first awards show, VEON: Women W...
19/11/2026
Gracenote, the content intelligence business unit of Nielsen, has extended its relationship with DIRECTV. Gracenote will continue to supply visual imagery and p...
19/11/2026
The Audio Engineering Society (AES) Technical Committee on Broadcast and Online ...
19/11/2026
NDI has released NDI 6.4, which adds Recording and Playback APIs, support for HEVC 4:4:4 and a configurable receiver buffer for Wi-Fi. The update also includes ...
19/11/2026
Lemonlight, the video production company behind more than 50,000 brand videos, has announced Hero, an AI production operating system, along with a new AI agent ...
19/11/2026
In a first-of-its-kind deployment at XFINITY Center, the digital signage/display...
19/11/2026
For the first time on a US streaming service, real-time player identification, contextual stats, and visual insights appear right in the live stream, available ...
19/11/2026
His career runs from the 2-in. videotape era to Canada's first HD and UHD live-production facilities...
19/11/2026
The popular sports-graphics event features a new Chairperson and new venue...
19/11/2026
Beth de Ara jo, Gemma Chan, Channing Tatum and Mason Reeves attend the premiere of Josephine at Eccles Theatre on January 23, 2026, in Park City, UT. (Photo b...
19/11/2026
New performance-focused brass library announced
Expressive E's latest release brings together four meticulously sampled brass instruments: sousaphone, b...
19/11/2026
Acoustic synthesizer gains free web editor
The phase8 acoustic synthesizer has been an ongoing project for Korg Berlin. It was unveiled as an early prototyp...
19/11/2026
MIDI controller keyboards upgraded
Designed for users who want a full-size keyboard and hands-on DAW control but in a relatively compact footprint, Nektar...
19/11/2026
Hugely popular compact monitor overhauled
IK Multimedia's ultra-compact monitors have proven to be incredibly popular, and the company say that they'...
19/11/2026
Rohde & Schwarz brings company-wide technology and service expertise to critical...
19/11/2026
On October 8, 2026, Nielsen employees came together around the world to celebrate our fourteenth company-wide day of service, Nielsen Global Impact Day (NGID). ...
19/11/2026
Integrating Gracenote's content intelligence with Nexxen's unique CTV supply allows advertisers to more closely align campaigns with audience viewing ha...
19/11/2026
Enhancement Mirrors Local TV's Recent Move to 1-Minute Qualifier (1MQ)
Upda...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , er...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
As Founder and Creative Director of Future Phonic Studios, the Netherlands' first Dolby Atmos music studio, Richard Burki has spent more than a decade pushi...
19/11/2026
Boris FX Black Friday Sale - 25% Off Everything
Brie Clayton November 19, 2026
0 Comments
Check out the Boris FX Black Friday sale on Monday, November...
19/11/2026
Virtual Production Finds Its Middle Ground with Blackmagic Design
Brie Clayton November 19, 2026
0 Comments
How Neon Vision is using PYXIS 12K and Ult...
19/11/2026
FL Studio Announces Black Friday Discounts of Up to 50% Across Its Software Line...
19/11/2026
TBS Drama Series Tagusari Brothers Uses DaVinci Resolve Studio
Brie Clayton November 19, 2026
0 Comments
TBS ACT streamlines post production for broad...
19/11/2026
Beeble launches SwitchX 3.0 with dynamic environments and greater creative contr...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , er...
19/11/2026
Five-year deployment has automated APL's media supply chain from fixture to archive, managing over 200,000 assets
Blue Lucy, the workflow orchestration and...
19/11/2026
Riding the Australian wave through co-pros 11 November 2026
L-R: The Surfer, We Bury the Dead
Australian stories are captivating global audiences and attracti...
19/11/2026
Screen Australia and Australian Film Television and Radio School announce the Fi...
19/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...